P Shapshak
Overview
Explore the profile of P Shapshak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1019
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shapshak P, Fujimura R, Srivastava A, Goodkin K
CNS Spectr
. 2008 Feb;
5(4):31-42.
PMID: 18277336
Infection with human immunodeficiency virus type 1 (HIV-1) leads rapidly to infection of the brain and subsequent neuropsychological impairment, including subclinical impairment, minor cognitive-motor disorder, and HIV-1-associated dementia (HAD). This...
2.
Goodkin K, Wilkie F, Baldewicz T, Concha M, Tyl M, Lopiccolo C, et al.
CNS Spectr
. 2008 Jan;
5(8):49-60.
PMID: 18192940
The diagnosis of human immunodeficiency virus type 1 (HIV-1)-associated cognitive-motor disorder--either minor cognitive-motor disorder (MCMD) or HIV-1-associated dementia (HAD)--is fraught with potential pitfalls for the clinician. Before making such a...
3.
Delgado S, Shapshak P, Stewart R, de la Vega P, Sun N, Benjamin S, et al.
J NeuroAIDS
. 2006 Jul;
2(1):79-97.
PMID: 16873187
Goal: To determine the heterogeneity of surface marker expression of macrophages in peripheral nerve of patients who died with AIDS. Background: Peripheral neuropathy occurs in 20%-40% of AIDS patients. There...
4.
Shapshak P, Duncan R, Torres-Munoz J, Duran E, Minagar A, Petito C
Front Biosci
. 2004 Sep;
9:2935-46.
PMID: 15353327
We previously showed that specific strains of human immunodeficiency virus (HIV)-1 infect the brain and contribute to Neuropathology, Cognitive Distress, and Neuropsychiatric Disease. To study further brain disease that results...
5.
Goodkin K, Wilkie F, Concha M, Hinkin C, Symes S, Baldewicz T, et al.
J Clin Epidemiol
. 2001 Dec;
54 Suppl 1:S35-43.
PMID: 11750208
Older individuals (>50 years of age) now comprise over 11% of patients with AIDS in the United States. This percentage is expected to continue to grow, due both to the...
6.
Goodkin K, Baldewicz T, Asthana D, Khamis I, Blaney N, Kumar M, et al.
J Hum Virol
. 2001 Feb;
4(1):44-54.
PMID: 11213933
Objectives: This study investigates the potential impact of a bereavement support group on plasma viral load. Methods: A randomly selected subsample of human immunodeficiency virus type 1 (HIV-1)-positive homosexual men...
7.
HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report
Shapshak P, Fujimura R, Page J, Segal D, Rivers J, Yang J, et al.
Drug Alcohol Depend
. 2000 Feb;
58(1-2):153-7.
PMID: 10669066
We quantified HIV-1 RNA load in rinses from needles/syringes (N/S) obtained at shooting galleries in Miami and also analyzed the rinses for antibodies for viral proteins. In rinses from 36...
8.
Petito C, Gendelman H, McCarthy M, Nath A, Podack E, Shapshak P, et al.
J Neurovirol
. 1999 Aug;
5(4):327-41.
PMID: 10463855
No abstract available.
9.
Shapshak P, Segal D, Crandall K, Fujimura R, Zhang B, Xin K, et al.
AIDS Res Hum Retroviruses
. 1999 Jun;
15(9):811-20.
PMID: 10381169
HIV-1-associated brain pathology exhibits regional variability and we therefore studied the genetic differences in the V1-V5 domains of the HIV env gene in up to four regions of brain (frontal...
10.
Segal D, Perez M, Shapshak P
J Acquir Immune Defic Syndr Hum Retrovirol
. 1999 Mar;
20(3):215-9.
PMID: 10077168
Antiviral agents are the primary therapy for patients infected with HIV-1. However, supportive therapies are often necessary in addition to antiviral drugs because of the devastating wasting process associated with...